Editor's key points † Impaired renal function before cardiac surgery worsens outcomes, but the threshold values are unclear. † In this large retrospective study, impaired preoperative renal function was common. † Baseline creatinine .115 mmol litre 21 and estimated glomerular filtration rate ≤50 ml min 21 were both associated with early and late mortality. † These data suggest that mild impairment of renal function is a significant risk factor for cardiac surgery.
have been included in several preoperative risk models, such as the Society of Thoracic Surgeons (STS) score and the EuroSCORE. 5 -9 Identifying patients with an augmented perioperative risk constellation can minimize their exposure to further renal insults during clinical management. 1 A number of variables are used to define renal function. For practical reasons, serum creatinine (SCr) and estimated glomerular filtration rate (eGFR) are most often used. 10 SCr, however, has several limitations, such as variations in concentration related to age, sex, and muscle mass. Therefore, several formulas have been developed for calculating eGFR as an alternative method that may allow more accurate assessment of renal function. 5 11 Despite some shortcomings, the Cockcroft -Gault formula 12 is most often used for perioperative risk stratification. However, the weighting of indicators of renal function in various scoring systems is quite variable, and the cut-off values for both SCr and eGFR have often been chosen based on expert opinion and not on data obtained in the population at risk. 13 In this study conducted in a large group of patients undergoing elective cardiac surgery, we analysed the cut-off values for risk stratification based on baseline SCr (bSCr) above which mortality increases. These results were validated by comparison with data obtained from similar patients at the University Hospital of Zurich, Switzerland, which is also a tertiary referral hospital. Furthermore, we evaluated the potential of eGFR determination, cut-off value identification, and allocation to chronic kidney disease (CKD) categories according to eGFR levels, for improved prediction of short-and long-term survival. Additionally, we determined whether renal risk is confounded by other perioperative risk indicators for short-and long-term survival.
Methods

Patients and protocols
The protocol was approved by the Ethics Committee of the Medical University of Vienna (EK Nr: 964/2011).
Between January 1, 1997, and December 31, 2008, all patients who underwent elective open heart surgery at the Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria, were recorded in the prospectively collected database of the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care Medicine. For this analysis, we included adult patients (.18 yr) who were undergoing coronary artery bypass grafting (CABG) [with or without cardiopulmonary bypass (CPB)], valve surgery, and combined procedures. Patients with the following interventions or conditions were excluded: transplant surgery, scheduled insertion of a cardiac assist device, operation on the aorta (e.g. thoracic aortic aneurysm repair), thromboendarterectomy of the pulmonary arteries, congenital heart disease, and emergency procedures. The following criteria were used to discriminate between urgent and emergency procedures: urgent operations were performed at or after the beginning of the next working day and the patient was required to remain in the hospital before surgery; emergency operations were performed immediately on referral to a surgeon or before the beginning of the next working day. 9 In the first screening of the database, 9981 patients were included and 385 patients were excluded because of miscoding (e.g. double entry, other surgery). Patients with missing bSCr values (n¼106) were also excluded. The criteria for patient selection and exclusion are shown in Figure 1 .
Surgery with CPB was performed according to institutional standards: crystalloid priming with 20 g of mannitol and 1 000 000 kallikrein inhibitor units of aprotinin, membrane oxygenator, intermittent antegrade and retrograde blood cardioplegia, and normothermic or hypothermic CPB, depending on indications and surgical preferences. Owing to safety concerns, 14 At the end of the follow-up period (December 31, 2010), the prospectively collected data from the clinical database were combined with those collected from the central laboratory and hospital central databases, the latter holding information from the Federal Austrian Statistical Office on the death of every patient in Austria. We did a complete follow-up for all included patients.
Perioperative risk indicators and complications
For the procedure itself, cases of urgent surgery, duration of anaesthesia and surgery, CPB and aortic cross-clamp time, and the amount of blood products [erythrocytes, fresh-frozen plasma (FFP), and platelets] that were given to the patients were entered into the analysis. The use of aprotinin and complications (e.g. unplanned insertion of an intra-aortic balloon pump (IABP), unscheduled insertion of an assist device, and emergency resternotomy) were also recorded. In cases of scheduled reoperation (e.g. a second aortic valve replacement), data from the most recent procedure were used. We also recorded the need for postoperative renal replacement therapy (RRT).
All computations were performed with PROC PHREG in SAS 9.3.
Outcome variables
bSCr was defined as the SCr value recorded closest to the time of surgery. In the case of reoperation within 14 days after the first intervention, the value before the first operation was used. bSCr concentration was measured in a certified laboratory using the Jaffe method on a Hitachi 747 analyser (until 2003, also 
Statistical analysis
Interval scaled risk indicators were expressed as means and (standard deviations), and categorical risk indicators were expressed as frequencies. The duration of follow-up was described as the median and inter-quartile range (IQR). Survival among the cohort was estimated by the Kaplan-Meier plot.
Our analysis comprised five steps.
Step 1 was to find an ideal cut-off value for bSCr high . The data were divided iteratively into two groups for every value between the minimum and maximum bSCr values with a step width of 5 mmol litre 21 .
Patients with bSCr values less than or equal to the potential cut-off value were assigned to Group 1 and those with bSCr values exceeding the potential cut-off value were assigned to Group 2. At each step, the non-parametric log-rank statistic, which measures the difference in overall survival functions, was calculated using PROC LIFETEST in SAS 9.3. The potentially ideal split point, according to this statistical test, was identified as the bSCr cut-off value that maximizes this statistic. This identification of a cut-off value was performed on the whole data set. Additional validation was performed on a subset of bSCr from the USZ data using the identical cut-off estimation. Receiver operating characteristic (ROC) curves were calculated to describe the characteristics of SCr values for the prediction of survival until a time-point of 150 days. The ROC curve for censored data were calculated according to the method based on the Kaplan-Meier estimation described by Heagerty and colleagues. 17 As a summary measure, the area under the ROC curve (AUC) was calculated. For the standard ROC curve from the study sample, 95% confidence intervals (CIs) for the AUC were calculated by the standard method of DeLong and colleagues. 18 For the AUC of the ROC curve for censored data, CIs were calculated as the 2.5% and 97.5% quantile of the empirical distribution from 1000 bootstrap samples.
In step 2, we performed the same analysis as in step 1 by identifying our patients according to the stages of CKD. 16 An ideal cut-off value for prediction of survival was calculated in the same way as that described for bSCr high . The step width applied here was 5 ml min 21 . We could not estimate eGFR in 69 patients (0.7%) because of missing body weight data. In step 3, the influence of risk indicators on overall survival was calculated using the simple Cox proportional hazard models for 45 risk indicators. The reference groups for those categorical risk indicators with more than two classes were, respectively, CKD stage 1, absence of angina pectoris, left ventricular ejection fraction (LVEF) .50%, and CABG. Hazard ratios Serum creatinine and post-cardiac surgery outcomes (HRs) with 95% CIs were used to quantify the effect of patient comorbidities and procedure-related risk indicators.
In step 4, a Kaplan -Meier estimate of the survival function including all patients was used to define the threshold of constant survival functions for short-and long-term survival.
In step 5, multiple proportional hazards models were calculated using stepwise forward -backward model selection based on the Bayesian information criterion. The scope of possible predictors comprised those risk indicators identified as significant in the univariate models. bSCr high was considered compulsory for the final model as it was the primary outcome parameter for the study. However, any risk indicators that were calculated from other risk indicators in the data set were excluded from the scope of potential predictors, with the exception of CKD stage 1-5. This was done to avoid a selection between highly correlated risk indicators. The following risk indicators were applied in the multiple models: bSCr high, CKD stage 1-5, sex, age, BMI, chronic heart failure, diabetes, angina pectoris, infarction, LVEF, atrial fibrillation, PAOD, COPD, history of CKD, diuretics, ACE-inhibitors, operation procedure (CABG, combined procedures, valve procedures, and off-pump CABG), surgery time, CPB time, aortic cross-clamp time, use of erythrocytes, FFP, platelets, urgent procedure, reoperation, IABP after CPB, assist device, RRT, revision within 48 h, and revision later than 48 h. In the analysis of short-term survival, survival times .150 days (estimated in step 4) were treated as censored data with survival time equal to 150 days. In the analysis of long-term survival, only patients with survival times .150 days were included (n¼8603 patients out of the total sample of 9490).
The analyses were performed with R 2.14.2 using the R packages survival. P-values of ,0.05 were considered significant.
Results
We analysed a total of 9490 patients with a mean age of 63 (13) yr, 35% of them female. For surviving patients, the median follow-up period was 5.9 yr (IQR 3.1-6.2), and the longest was 13.6 yr. Data from 6182 patients surviving at the end of 2010 were censored within the 13.6 yr observation period, and 3308 patients died.
Over the observational period, the mean patient age increased from 64.7 to 66.8 yr, with an increase in the EuroSCORE from 8.3 to 9.9. Patients underwent surgery as follows: CABG, 39.2% (n¼3716); combined procedure, 19.8% (n¼1882); off-pump CABG, 7.2% (n¼688); and valve operations, 33.8% (n¼3204). Diabetes was found in 24.1% (2294 patients), and 29.4% (2795 patients) had a previous myocardial infarction. Reduced ejection fraction (≤50%) was diagnosed in 44.8% (4254 patients). In total, 85.1% (8073) of patients treated with aprotinin, and no significant differences were observed compared with the data collected for those who received tranexamic acid (P¼0.5568). All patients and surgical characteristics are shown in Table 1 .
The log-rank test statistic (steps 1 and 2) indicated that .115 mmol litre 21 was the cut-off value for bSCr high , and (Fig. 2) . The 43 risk indicators identified in the univariate analysis (step 3) are shown in Table 2 .
The whole cohort survival curves show an early phase of rapidly declining survival in the first 150 postoperative days (Fig. 2) . Inspection of the logarithm of the survival function showed a clear change in the slope during the initial 150 days and an approximately constant slope after 150 days. Serum creatinine and post-cardiac surgery outcomes This indicates that the overall hazard as a function of time is approximately stable after 150 days, indicating a possibly different risk regimen after the initial 150 days (step 4).
In the multivariate analysis (step 5), we identified 12 risk indicators for the short term and 14 risk indicators for the long term (Table 2) . A partial difference in the patient characteristics, medical, and perioperative risk indicators was identified between short-and long-term outcomes. bSCr high had an HR of 1.59 (95% CI 1.38 -1.83; P¼0.0027) for the short-term analysis and an HR of 1.46 (95% CI 1.32-1.62; P,0.0001) for the long-term analysis.
CKD stages were not found to be independent risk indicators in the short-and long-term analyses.
Discussion
In this study on a large group of patients undergoing elective cardiac surgery, the risk of mortality was directly associated with an increasing bSCr. The cut-off for bSCr high , above which mortality started to increase, was 115 mmol litre 21 . In 20% of patients, bSCr was above this threshold, with an associated doubling in the risk of death (HR 2.61). bSCr high was also a predictor for short-term (HR 1.59) and even long-term (HR 1.46) mortality even when a large number of additional risk indicators were also considered. We validated our bSCr cut-off value in data collected from another cardiac surgical centre in a different country. Despite some differences in the patient populations and preoperative risk profiles, 16 the resulting cut-off values were almost identical: 115 vs 120 mmol litre 21 .
Complete follow-up data were available for every included patient for at least 2 yr; therefore, we also aimed to identify important risk indicators in the long term. In our cohort, an early phase of rapid decline in survival was found within 150 days. This finding has important implications for the postoperative care of cardiac surgical patients.
We were not able to show significant risk stratification of CKD stages in the multivariate analysis. This is probably because of a relevant statistical collinearity since eGFR is composed from age, gender, and SCr (and, therefore, is in itself the result of several risk indicators). Female gender, for example, was identified as an advantage for long-term survival in the multivariate analysis. In eGFR, SCr, by definition, forms only a part of the estimation in contrast to bSCr alone, which was revealed as the most important component of the renal-based risk estimation in these patients. Our results demonstrate that 'bSCr' is a simple surrogate marker that is sufficient and predictive for short-and long-term mortality after cardiac surgery. Furthermore, this marker forms the basis and the result of appropriate multivariate analysis without considering some factors twice (age, gender).
The cut-off for eGFR was ≤50 ml min 21 ; thus, nearly 25% of cardiac surgery patients were at risk. There was a strong indirect correlation between eGFR and mortality. We also tested the hypothesis that division of eGFR into five CKD stages improves preoperative risk stratification. Patients in CKD stages 3 -5 had a significantly higher risk in the univariate analysis described previously; this effect was lost when some of the other risk indicators were taken into account for the short-and long-term multivariate analysis. The threshold of bSCr above which mortality started to increase was lower than the bSCr cut-off value of .200 mmol litre 21 used in EuroSCORE. 9 The newer version of EuroSCORE II 8 uses eGFR instead of absolute SCr and recommends the use of the Cockcroft -Gault formula. Because of this, we estimated GFR by using the older formula and not the newer ones, such as the Modification of Diet in Renal Disease formula 19 or the Chronic Kidney Disease Epidemiology Collaboration formula. 20 Again all these formulas include age, weight, and sex, and these factors (age and being female) are weighted twice in various risk scores. The use of eGFR rather than bSCr for risk stratification can be associated with considerable variance and incorrect allocation of patients to risk class. Nevertheless, despite the many shortcomings of SCr in the estimation of renal function, the calculation of eGFR, and the derived classification into CKD stages did not improve the risk stratification in our model; therefore, we question whether it is necessary to calculate eGFR. We propose to use bSCr high in clinical practice, because it does not require any other information and can be used in emergencies.
Elevated bSCr values before any type of operation obviously reflect higher risk situations: patients undergoing non-elective surgery often exhibit deranged metabolic status because of cardiac disease, which accelerates the necessity for surgery. We did not compare our estimations with those of the STS risk scores, because it has been shown that EuroSCORE performs remarkably well in North American cardiac surgery patients, despite substantial differences in patient, risk, and surgical characteristics between Europeans and Americans. 21 After operation, RRT was needed nearly five times as often as preoperative chronic haemodialysis and presented almost a four-fold higher risk of mortality in the first 150 days. The decreasing risk in the long-term outcome further supports the hypothesis that the need for RRT is not a risk indicator but a very serious intermediate outcome. 16 Renal injury itself further increases the risk of developing potentially lethal severe non-renal complications. 22 23 Several independent risk indicators reflecting perioperative problems (e.g. CPB duration, reoperation) were significant only in the short term; risk indicators closely connected with haemodynamic instability, haemodilution, anaemia and erythrocyte transfusion, inflammation, and ischaemia-reperfusion injury. Some of these risks may be modifiable, but not readily and not in every patient. Therapies aimed at mitigating preoperative anaemia and avoiding erythrocyte transfusion may offer protection. 24 25 Fluid overload, which may also contribute to renal injury because of direct interstitial oedema and intra-abdominal hypertension, is a modifiable risk indicator. 26 Not surprisingly, a variety of non-modifiable risk indicators or comorbidities (e.g. diabetes, limited ejection fraction) reduce the chances of long-term survival and may be risk indicators for other postoperative complications (e.g. infection, prolonged hospital stay) that we did not observe. bSCr high , age, the need for erythrocyte transfusion, and RRT were the only significant risk indicators for both short-and long-term mortality.
An unexpected finding was the positive effect of stable angina on short-term survival, which may be explained by appropriate preoperative treatment and an accompanied better preoperative state.
A cohort study such as ours may be limited by bias owing to omitted or unobserved confounding risk indicators. We included the most relevant risk indicators to minimize this bias. However, changes in surgical and anaesthetic management during the long observational period were not considered in our study. The University Hospital of Vienna is the largest centre and the tertiary referral centre for eastern Austria. Owing to difficulties in determining the cause of death for so many patients, we analysed overall mortality but not cardiac surgery-related mortality. We matched the mortality data provided by the Federal Austrian Statistical Office with the hospital mortality data, so an information bias because of missing deaths in our cohort is unlikely.
In conclusion, the cut-off value for bSCr high was .115 mmol litre 21 and for eGFR, ≤50 ml min 21 : patients with a bSCr high , representing 19.5% of our cohort, had a highly relevant risk of mortality. Clinicians must be alerted whenever this value is above normal to avoid further renal damage during the entire perioperative period.
In contrast to postoperative kidney-injury models composed of several variables, 27 
